Initial reports suggest that COVID-19 can be particularly lethal in patients with cancer. This commentary discusses how to balance a delay in cancer diagnosis or treatment against the risk for a potential COVID-19 exposure, mitigate the risks for significant care disruptions associated with social distancing behaviors, and manage the appropriate allocation of limited health care resources in this unprecedented time of health care crisis.

Original languageEnglish
Pages (from-to)759-760
Number of pages2
JournalAnnals of Internal Medicine
Issue number11
StatePublished - May 2 2020


  • COVID-19
  • Cancer chemotherapy
  • Cancer treatment
  • Drug delivery system preparation
  • Health care
  • Health care providers
  • Hereditary nonpolyposis colorectal cancer
  • Patients
  • Prevention, policy, and public health
  • Respiratory system procedures


Dive into the research topics of 'A War on Two Fronts: Cancer care in the time of COVID-19'. Together they form a unique fingerprint.

Cite this